Suzanne R.L. Young - Concepedia

Author

Suzanne R.L. Young

Indiana University – Purdue University Indianapolis

Also Known As

S Young, S. R. YOUNG, Suzanne R. L. Young, Suzanne R. Young, Suzanne R.L. Young, Suzanne RL Young, Suzanne Young

Publications

737

Citations

H-Index

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine Eli Lilly (United States)Memorial Sloan Kettering Cancer Center Dana-Farber Cancer Institute

About

Suzanne R.L. Young is an author at Indiana University – Purdue University Indianapolis specializing in medicine, cell biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	426
2	Cell Biology	6	6	354
3	Engineering	1	1	142
4	Health Sciences	1	1	18
5	Natural Sciences	1	1	98

Suzanne R.L. Young

Publications

712

Citations

H-Index

Page 1

	Year	Citations
Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer Curtis Balch, Pearlly S. Yan, Teresa Craft, Molecular Cancer Therapeutics	2005	142
Focal Adhesion Kinase Is Important for Fluid Shear Stress-Induced Mechanotransduction in Osteoblasts Suzanne R.L. Young, Rita Gerard-O’Riley, Jae-Beom Kim, Journal of Bone and Mineral Research MechanobiologyFocal AdhesionsFocal Adhesion KinaseEngineeringOrthopaedic Surgery	2008	142
Reduced Genomic Cytosine Methylation and Defective Cellular Differentiation in Embryonic Stem Cells Lacking CpG Binding Protein Diana L. Carlone, Jeong‐Heon Lee, Suzanne R.L. Young, Molecular and Cellular Biology Epigenetic ChangeGeneticsDna MethylationCytosine MethylationDefective Cellular Differentiation	2005	98
A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer Panagiotis A. Konstantinopoulos, Jungmin Lee, Bo Gao, Gynecologic Oncology	2022	63
Updated efficacy, safety, & PD-L1 status of patients with HR+, HER2- metastatic breast cancer administered abemaciclib plus pembrolizumab. Sara M. Tolaney, Peter Kabos, Maura N. Dickler, Journal of Clinical Oncology Breast OncologyPd-l1 InhibitorsImmunologyPharmacotherapyImmunotherapeutics	2018	40
Activation of NF-κB by fluid shear stress, but not TNF-α, requires focal adhesion kinase in osteoblasts Suzanne R.L. Young, Rita Gerard-O’Riley, Maureen A. Harrington, Bone MechanobiologyInflammationFocal Adhesion KinaseBone Morphogenic ProteinFluid Shear Stress	2010	38
A first-in-human phase 1a/b trial of LY3484356, an oral selective estrogen receptor (ER) degrader (SERD) in ER+ advanced breast cancer (aBC) and endometrial endometrioid cancer (EEC): Results from the EMBER study. Komal Jhaveri, Elgene Lim, Erika Hamilton, Journal of Clinical Oncology Breast OncologyGynecologyPharmacotherapyOncologyEndometrial Endometrioid Cancer	2021	36
Non-Overlapping Functions for Pyk2 and FAK in Osteoblasts during Fluid Shear Stress-Induced Mechanotransduction Suzanne R.L. Young, Julia M. Hum, Eric Rodenberg, PLoS ONE	2011	30
Antisense Targeting of CXXC Finger Protein 1 Inhibits Genomic Cytosine Methylation and Primitive Hematopoiesis in Zebrafish Suzanne R.L. Young, Christen L. Mumaw, James A. Marrs, Journal of Biological Chemistry Epigenetic ChangeGeneticsGenomic MechanismEpigeneticsPrimitive Hematopoiesis	2006	22
Nmp4/CIZ inhibits mechanically induced β‐catenin signaling activity in osteoblasts Zhouqi Yang, Joseph P. Bidwell, Suzanne R.L. Young, Journal of Cellular Physiology	2010	22

Page 1